Data further examines Seroquel® (quetiapine fumarate) treatment for bipolar depression (EurekAlert!)

home   >   yahoo news

WILMINGTON, Del., Monday May 23 2005 ? AstraZeneca (NYSE: AZN) today announced results from a clinical study that examined the effectiveness of SEROQUEL and risperidone in improving cognitive function, such as memory and attention, in patients with schizophrenia.

- link to Data further examines Seroquel® (quetiapine fumarate) treatment for bipolar depression (EurekAlert!) -
Last update: 05/26/2005

Recommended Reading

    Developmental disorders respond to Quetiapine: moderate to high dose.(Behavioral Pediatrics) : An article from: Pediatric News
    Drug shortages challenge long-term patient care: Number of products affected up sharply. ('Domino Effect'). : An article from: Clinical Psychiatry News
    Primer for Prescription Medications: the antipsychotic medicines--atypical. : An article from: Annals of the American Psychotherapy Association
    Primer for Prescription Medications: the antipsychotic medicines--atypical. : An article from: Annals of the American Psychotherapy Association
    Drug shortages challenge long-term patient care: Number of products affected up sharply. ('Domino Effect'). : An article from: Clinical Psychiatry News
    Quetiapine promising for developmental disorders. (Children and Teens). : An article from: Clinical Psychiatry News
    Seroquel shortage indicative of supply problems. (Sharp Increase in Drug Shortages). : An article from: Internal Medicine News
    Seroquel - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References